Evidence map›Paper›PMID 28466151›Full record

Trial reportIntensive care medicine2017

Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial.

Frank Bloos, Hendrik Rüddel, Daniel Thomas-Rüddel, Daniel Schwarzkopf, Christine Pausch, Stephan Harbarth, Torsten Schreiber, Matthias Gründling, John Marshall, Philipp Simon and 19 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Intensive care medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01187134 (Medical Education for Sepsis Source Control and Antibiotics), which is not on this map. Cited by 93 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 6 pooled it
12.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01187134 nacompletednot on this map

Medical Education for Sepsis Source Control and Antibiotics

TypeinterventionalSponsorCenter for Sepsis Control and Care, GermanyRan2011 to 2013Enrolled4,138ConditionsSepsis, Shock, SepticArmsChange Management
3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 6 syntheses or guidelines pooled it, 197 citations in OpenAlex.

  1. [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Guideline
  2. Audit and feedback: effects on professional practice.The Cochrane database of systematic reviews · 2025
    Pooled it
  3. Pooled it
  4. [Early source control of infection in patients seen in the emergency department: a systematic review].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2024
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
  16. Validation of CRownLab Pneumoplex for the Detection ofInternational journal of microbiology · 2026
    Article
  17. Review
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 14 institutions in 4 countries.

Frank BloosCenter for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Hendrik RüddelCenter for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Daniel Thomas-RüddelCenter for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Daniel SchwarzkopfCenter for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Christine PauschInstitute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
Stephan HarbarthService Prévention et Contrôle de l'Infection, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
Torsten SchreiberDepartment of Anaesthesia and Intensive Care Medicine, Zentralklinik Bad Berka GmbH, Bad Berka, Germany.
Matthias GründlingDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Greifswald, Greifswald, Germany.
John MarshallDepartment of Surgery and the Li Ka Shing Knowledge Institute, St Michael's Hospital, University of Toronto, Ontario, Canada.
Philipp SimonDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Leipzig, Leipzig, Germany.
Mitchell M LevyDivision of Pulmonary and Critical Care Medicine, Warren Alpert Medical School of Brown University, Providence, RI, USA.
Manfred WeissDepartment of Anesthesiology, University Hospital Ulm, Ulm, Germany.
Andreas WeylandDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Oldenburg, Oldenburg, Germany.
Herwig GerlachDepartment of Anesthesiology, Surgical Intensive Care Medicine and Pain Therapy, Vivantes Hospital Neukölln, Berlin, Germany.
Tobias SchürholzDepartment of Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany.
Christoph EngelInstitute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
Claudia Matthäus-KrämerCenter for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Christian ScheerDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Greifswald, Greifswald, Germany.
Friedhelm BachDepartment of Anesthesiology, Intensive Care, Transfusion and Emergency Medicine and Pain Therapy, Bethel Hospital Bielefeld, Bielefeld, Germany.
Reimer RiessenDepartment of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
Bernhard PoidingerCenter for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany.
Karin DeyDepartment of Anesthesiology and Intensive Care Medicine, Hospital of the Bundeswehr Berlin, Berlin, Germany.
Norbert WeilerDepartment of Anesthesiology and Intensive Care Medicine, University Medical Center Kiel, Kiel, Germany.
Andreas Meier-HellmannDepartment of Anesthesiology, Intensive Care Medicine and Pain Therapy, Helios Hospital Erfurt, Erfurt, Germany.
Helene H HäberleDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Tübingen, Tübingen, Germany.
Gabriele WöbkerDepartment of Intensive Care Medicine, Helios Hospital Wuppertal, Wuppertal, Germany.
Udo X KaisersDepartment of Anesthesiology and Intensive Care Medicine, University Hospital Leipzig, Leipzig, Germany.
Konrad ReinhartCenter for Sepsis Control and Care (CSCC), Jena University Hospital, Jena, Germany. konrad.reinhart@med.uni-jena.de.
MEDUSA study group
Jena University Hospital · DEUniversitätsmedizin Greifswald · DEBrown University · USBundeswehrkrankenhaus · DEHelios Universitätsklinikum Wuppertal · DEHôpital Beau-Séjour · CHKlinikum Oldenburg · DESt. Michael's Hospital · CAUniversity Children's Hospital Tübingen · DEEvangelisches Krankenhaus Bielefeld · DEHelios Klinikum Erfurt · DEUniversity Hospital Leipzig · DEUniversity of Rostock · DEVivantes Klinikum · DE

Funding

Bundesministerium für Bildung und Forschung FKZ 01EO1002
6 · The paper itself

Abstract

purposeGuidelines recommend administering antibiotics within 1 h of sepsis recognition but this recommendation remains untested by randomized trials. This trial was set up to investigate whether survival is improved by reducing the time before initiation of antimicrobial therapy by means of a multifaceted intervention in compliance with guideline recommendations.

methodsThe MEDUSA study, a prospective multicenter cluster-randomized trial, was conducted from July 2011 to July 2013 in 40 German hospitals. Hospitals were randomly allocated to receive conventional continuous medical education (CME) measures (control group) or multifaceted interventions including local quality improvement teams, educational outreach, audit, feedback, and reminders. We included 4183 patients with severe sepsis or septic shock in an intention-to-treat analysis comparing the multifaceted intervention (n = 2596) with conventional CME (n = 1587). The primary outcome was 28-day mortality.

resultsThe 28-day mortality was 35.1% (883 of 2596 patients) in the intervention group and 26.7% (403 of 1587 patients; p = 0.01) in the control group. The intervention was not a risk factor for mortality, since this difference was present from the beginning of the study and remained unaffected by the intervention. Median time to antimicrobial therapy was 1.5 h (interquartile range 0.1-4.9 h) in the intervention group and 2.0 h (0.4-5.9 h; p = 0.41) in the control group. The risk of death increased by 2% per hour delay of antimicrobial therapy and 1% per hour delay of source control, independent of group assignment.

conclusionsDelay in antimicrobial therapy and source control was associated with increased mortality but the multifaceted approach was unable to change time to antimicrobial therapy in this setting and did not affect survival.

Indexed as

Guideline AdherenceQuality ImprovementTime-to-TreatmentAgedAnti-Bacterial AgentsEducation, ContinuingFemaleHospital MortalityHumansIntensive Care UnitsIntention to Treat AnalysisLength of StayMaleMiddle AgedProspective StudiesRisk FactorsAnti-Bacterial AgentsAntimicrobial agentsCritical illnessQuality improvementSeptic shock/drug therapy

Identifiers

PMID28466151
OpenAlexW2610730883

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.